Trades on 4 secondary markets

Verge Genomics

Verge Genomics (now operating as Verge Labs) is an AI-driven drug discovery biotechnology company using human genomics data and machine learning to discover and develop treatments for neurodegenerative and neuromuscular diseases such as ALS and Parkinson's. Its proprietary all-in-human CONVERGE plat

minimal 5.7 / 100 0 APIs View provider profile →

Company Biotechnology Drug Discovery Genomics Artificial Intelligence Machine Learning

Verge Genomics is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.